(Q34547931)

2 August 2017

1 reference

title

Control of multiply resistant cocci: do international comparisons help? (English)

1 reference

2 August 2017

S Harbarth

1

1 reference

2 August 2017

W Albrich

series ordinal

2

1 reference

2 August 2017

D A Goldmann

series ordinal

3

1 reference

2 August 2017

J Huebner

series ordinal

4

1 reference

2 August 2017

publication date

1 November 2001

1 reference

Lancet Infectious Diseases

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

251-261

1 reference

Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975-1995. Study Group Bacterial Resistance of the Paul-Ehrlich-Society for Chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Prevalence of vancomycin-resistant enterococci in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Staphylococcus aureus bacteremia--consider the source

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Differences Between American and German Medical Students and Physicians in Knowledge of Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Identification of enterococci and determination of their glycopeptide resistance in German and Austrian clinical microbiology laboratories.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

European standards for antibiotic susceptibility testing: towards a theoretical consensus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Epidemiology, control and treatment of multiresistant gram-negative rods.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Apparent differences in antimicrobial susceptibility as a consequence of national guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Penicillin-resistant Streptococcus pneumoniae in Germany: genetic relationship to clones from other European countries.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to German hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Host specificity of vancomycin-resistant Enterococcus faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Bacteriocin production in vancomycin-resistant and vancomycin-susceptible Enterococcus isolates of different origins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Emergence of vancomycin-resistant enterococci in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Problems with antibiotic resistance in Spain and their relation to antibiotic use in humans elsewhere

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Variation in antibiotic use in the European Union

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Excessive antibiotic use for acute respiratory infections in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antimicrobial use in defined populations of infants and young children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antibiotic resistance worldwide--a Spanish task force responds

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Compliance of German pediatric patients with oral antibiotic therapy: results of a nationwide survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Historical yearly usage of vancomycin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Parenteral antibiotic use in acute-care hospitals: A standardized analysis of fourteen institutions.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antimicrobial drug use in hospitals in The Netherlands, Germany and Belgium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antimicrobial expenditures and usage at four university hospitals. Baden-Württemberg Interuniversity Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Variation in antimicrobial utilization for febrile neutropenia in cancer patients. The CEMIC Study Group. Club d'Etudes des Maladies Infectieuses en Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Trends in infectious diseases mortality in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Trends in antimicrobial drug prescribing among office-based physicians in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

A comparison of severity of illness scoring systems for intensive care unit patients: results of a multicenter, multinational study. The European/North American Severity Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antibiotic use in Dutch hospitals 1991-1996

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

The German experience in reference pricing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

The pharmaceutical industry--to whom is it accountable?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antibiotic policy and penicillin-G shortage

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

The relation between purulent manifestations and antibiotic treatment of upper respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Parents, physicians, and antibiotic use.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Editorial response: Judicious use of antimicrobial agents for respiratory tract infections in children--why are the pediatricians in Toronto doing so well?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Antibiotic resistance in Streptococcus pneumoniae isolated from children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

American medical malpractice litigation in historical perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Reasons for noncompliance with infection control guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Improving compliance with hand hygiene in hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Using alcohol for hand antisepsis: dispelling old myths

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

Detection of pathogen transmission in neonatal nurseries using DNA markers as surrogate indicators

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

[Reasonable and unreasonable hygiene measures in anesthesia in the intensive care unit]

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900120-7

7 January 2021

10.1016/S1473-3099(01)00120-7

Identifiers

DOI

1 reference

2 August 2017

1 reference